A number of therapeutic approaches have been proposed to enhance the anti-tumor effect of suicide gene therapy by inducing an immune response to tumor cells via co-expression of cytokine genes, such as IL-2 [23], IL-2 and TNF-α [24], IL-12 [13], and IL-21 [25]. The gene discussed is IL21; the disease is neoplasm.